Skip to main content

Corcept Therapeutics Inc

CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001088856

In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Corcept Therapeutics Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
368
+52 vs. Q3 2024
Shares held
84.3M
−3.98M (−4.5%) vs. Q3 2024
Total value
$4.25B
+$162.7M (+4.0%) vs. Q3 2024
New holders
82
116 more added
Sold out
30
124 more reduced

5 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CORT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 368 institutions
Q1 2021: 210 institutionsQ2 2021: 199 institutionsQ3 2021: 202 institutionsQ4 2021: 208 institutionsQ1 2022: 228 institutionsQ2 2022: 226 institutionsQ3 2022: 239 institutionsQ4 2022: 244 institutionsQ1 2023: 233 institutionsQ2 2023: 225 institutionsQ3 2023: 247 institutionsQ4 2023: 274 institutionsQ1 2024: 285 institutionsQ2 2024: 286 institutionsQ3 2024: 321 institutionsQ4 2024: 368 institutionsQ1 2025: 422 institutionsQ2 2025: 422 institutionsQ3 2025: 429 institutionsQ4 2025: 390 institutionsQ1 2026: 352 institutionsQ2 2026: 424 institutions
Value heldQ4 2024: $4.25B
Q1 2021: $1.94BQ2 2021: $1.77BQ3 2021: $1.59BQ4 2021: $1.59BQ1 2022: $1.84BQ2 2022: $2.02BQ3 2022: $2.23BQ4 2022: $1.69BQ1 2023: $1.89BQ2 2023: $1.81BQ3 2023: $2.26BQ4 2023: $2.75BQ1 2024: $2.36BQ2 2024: $2.90BQ3 2024: $4.09BQ4 2024: $4.25BQ1 2025: $9.24BQ2 2025: $5.79BQ3 2025: $6.41BQ4 2025: $2.67BQ1 2026: $3.20BQ2 2026: $7.15B
Institutions holding CORT and their total value by quarter
QuarterHoldersValue
Q2 2026424$7.15B
Q1 2026352$3.20B
Q4 2025390$2.67B
Q3 2025429$6.41B
Q2 2025422$5.79B
Q1 2025422$9.24B
Q4 2024368$4.25B
Q3 2024321$4.09B
Q2 2024286$2.90B
Q1 2024285$2.36B
Q4 2023274$2.75B
Q3 2023247$2.26B
Q2 2023225$1.81B
Q1 2023233$1.89B
Q4 2022244$1.69B
Q3 2022239$2.23B
Q2 2022226$2.02B
Q1 2022228$1.84B
Q4 2021208$1.59B
Q3 2021202$1.59B
Q2 2021199$1.77B
Q1 2021210$1.94B

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Corcept Therapeutics Inc; share changes are against Q3 2024.

Institutions holding CORT in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Raymond James Trust N.A.––––Not filed
FinTrust Capital Advisors, LLC––––Not filed
Planning Capital Management Corp––––Not filed